Breaking the Silence: Fem+ 2024 Redefining Women's Health

Strategic Insights -

Fem+ 2024 marks a significant milestone in redefining women's health by focusing on perimenopause, a critical yet understudied phase in women's lives. This transition period, which affects women in their mid-30s to early 40s, is characterized by fluctuating estrogen levels and a range of symptoms, including irregular periods, hot flashes, and mood swings. As Fem+ 2024 provides in-depth insights into the challenges of perimenopause, it offers a platform for attendees to engage with the latest research and cutting-edge solutions aimed at improving women's quality of life.

Key Takeaways:

  • The event will explore the challenges of perimenopause with strategies to manage diverse symptoms, including irregular periods, hot flashes, and mood swings.
  • Fem+ 2024 is set to provide a platform for attendees to engage with the latest research and innovative solutions aimed at improving women's quality of life during the transitional period.
  • Japan's Ministry of Health, Labor, and Welfare has reported that most women in the country endure menopausal symptoms without consulting a doctor, often navigating this phase without seeking medical advice.
  • Men's understanding of menopause is also limited, inspiring the creation of Fem+ to provide solutions and treatments to enhance health outcomes and improve quality of life for women.
  • The event will address perimenopause and other critical issues in women's health, making Fem+ Japan's premier platform for women's healthcare innovation.
  • Fem+ 2024 aims to bridge the gap in awareness and support for menopause, offering a comprehensive exploration of the latest research and management strategies for perimenopause.

Statistics:

  • The survey by Japan's Ministry of Health, Labor, and Welfare found that most women in the country endure menopausal symptoms without consulting a doctor.
  • Perimenopause can start in the mid-30s to early 40s, characterized by fluctuating estrogen levels and a range of symptoms.
  • Fem+ 2024 will take place from October 17-19, 2024, at Tokyo Big Sight.

Sources:

  • Mayo Clinic
  • Japan's Ministry of Health, Labor, and Welfare
  • RX Japan Fem+ Events team
  • Fem+ official website: https://www.femtech-week.jp/